Clinical trial
To Evaluate the Lot-to-lot Consistency of Immunogenicity, Safety, and Immune Persistence of Three Consecutive Commercial Manufacturing Batches of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell) in Children Aged 6-35 Months in a Randomized, Blinded Study
NCT06146088 is registered in ClinicalTrials.gov with Institute of Medical Biology, Chinese Academy of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Evaluate the Lot-to-lot Consistency of Immunogenicity, Safety, and Immune Persistence of Three Consecutive Commercial Manufacturing Batches of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell) in Children Aged 6-35 Months in a Randomized, Blinded Study
- Lead sponsor
- Institute of Medical Biology, Chinese Academy of Medical Sciences
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- November 25, 2023
- Completion date
- July 15, 2026
- Enrollment
- 1,500 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.